The Surging Cancer Cases Fueling Expansion In The Tissue Microarray Market Driver: Leading Transformation in the Tissue Microarray Market in 2025

What combination of drivers is leading to accelerated growth in the tissue microarray market?
The rise in cancer incidences is anticipated to boost the expansion of the tissue microarray market. Cancer encompasses a range of diseases that can originate in any organ or tissue. This occurs when abnormal cells multiply uncontrollably, exceed their normal boundaries, and either metastasize to other organs or invade neighboring body parts. Tissue arrays are employed in oncology to investigate the expression of cancer-related biomarkers in multiple tumor specimens. For example, in June 2022, data released by Macmillan Cancer Support, a UK-based cancer charity, showed that the cancer prevalence had hit 3 million in 2022. This figure is expected to surge to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Therefore, the increasing number of cancer patients is fuelling the expansion of the tissue microarray market.

Get Your Tissue Microarray Market Report Here:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

What is the projected compound annual growth rate (CAGR) of the tissue microarray market from 2025 to 2034, and what factors influence it?
In recent years, the tissue microarray market has seen substantial growth. Its value, which stands at $12.05 billion in 2024, is expected to increase to $13.23 billion in 2025, marking a compound annual growth rate (CAGR) of 9.8%. This impressive development over the historical period has been motivated by factors such as the emergence of precision medicine, advancements in drug discovery and development, efficient analysis methods, increasing instances of chronic diseases, and initiatives towards biobanking.

The market size for tissue microarrays is anticipated to experience swift expansion in the coming years. The projected growth figure is $20.95 billion by 2029, with an annual compound growth rate of 12.2%. Factors contributing to this anticipated growth during the forecast period include the rise of digital pathology, widened applications, biopharmaceutical industry growth, regulatory backing and standards, and the integration of AI and machine learning. Key trends during this period will likely encompass advances in imaging technologies, the creation of 3D tissue microarrays, high-content screening, standardization efforts, and the incorporation of single-cell analysis.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

How are the latest trends influencing the growth of the tissue microarray market?
Establishing strategic alliances is a burgeoning trend in the tissue microarray market. Several prominent businesses in this market are forming partnerships to cultivate relationships that promote the development of tissue microarray technologies. For example, in November 2022, The Cureline Group, known for its translational and precision medicine CRO services, including HBS biobanking and lab services in the United States, formed a partnership with Cellecta Inc., an American producer of RNAi and CRISPR screening products and services. Together, they launched Tissue 2 Target Services, a fresh strategic collaboration aimed at merging their respective expertise in the molecular analysis of cells and tissues, and human biospecimen management. Their aim is to provide pre-clinical and translational research services specializing in gene target and biomarker discovery services designed to optimise workflows. Subsequently, in September 2022, Ultivue Inc., an American biotech company that creates reagent-based solutions to unlock maximum biological information from cells and tissue samples, joined forces with ngTMA, the Translational Research Unit (TRU) platform of the University of Bern in Switzerland, which focuses on innovating workflows for constructing tissue microarrays. This alliance aims to push forward the development of multiplexed immunofluorescence (mIF) assays and leverage new TMA technologies to unlock spatial analysis in scientific research whilst boosting the quality of TMAs utilized in clinical and translational research.

What are the major segments of the tissue microarray market and their role in driving growth?
The tissue microarray market covered in this report is segmented -

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting
3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

Which regions are key players in the growth of the tissue microarray market?
North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the tissue microarray market?
Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

What Is Covered In The Tissue Microarray Global Market Report?

• Market Size Forecast: Examine the tissue microarray market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the tissue microarray market for a structured understanding.
• Key Players Overview: Analyze major players in the tissue microarray market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the tissue microarray market.
• Segment Contributions: Evaluate how different segments drive overall growth in the tissue microarray market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the tissue microarray market.
• Industry Challenges: Identify potential risks and obstacles affecting the tissue microarray market.
• Competitive Landscape: Review strategic developments in the tissue microarray market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.